Search - tctmd.com

Displaying 201 - 220 of 4220

Sort: Relevancy | Date

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

News Daily News

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Yael L. Maxwell

April 25, 2025

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

April 23, 2025

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

News Daily News

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

April 17, 2025

The EARTH-STEMI Trial

Podcast TCTMD Talking Points

The EARTH-STEMI Trial

April 16, 2025

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

News Daily News

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

April 14, 2025

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

April 11, 2025

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

News Conference News EHRA 2025

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

April 09, 2025

The SCOFF Trial

Podcast TCTMD Talking Points

The SCOFF Trial

April 09, 2025

Positive Results With Volt Pulsed-Field Ablation System

News Conference News EHRA 2025

Positive Results With Volt Pulsed-Field Ablation System

April 07, 2025

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

News Conference News ACC 2025

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

April 02, 2025

The RESHAPE-HF2 and MATTERHORN Trials

Podcast TCTMD Talking Points

The RESHAPE-HF2 and MATTERHORN Trials

April 02, 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

March 31, 2025

Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II

News Conference News ACC 2025

Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II

March 31, 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

News Conference News ACC 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

March 30, 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

March 30, 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

Uncertainties Remain About Same-Day Discharge After AF Ablation

News Conference News EHRA 2025

Uncertainties Remain About Same-Day Discharge After AF Ablation

March 30, 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.